NEA
Click for more information
0.00% $2.10 nearmap ltd

15 October 2019Why Nearmap shares raced higher todayThe Nearmap...

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. birdman29
    28,793 Posts.
    lightbulb Created with Sketch. 481
    clock Created with Sketch.
    15/10/19
    20:05
    Post #: 40895958
    15 October 2019

    Why Nearmap shares raced higher today


    The Nearmap Ltd (ASX: NEA) share price has climbed 3% to $2.60. This morning the aerial imagery technology and location data company released its annual report. Whilst there was no new information in the report, it reminded investors that the company has a massive market opportunity. Despite generating sizeable revenues already in North America, management estimates that it has market penetration of just 1%-2% in the region.

    https://au.finance.yahoo.com/news/why-afterpay-nearmap-praemium-superloop-023700526.html
    NEA Price at posting: $2.68 Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 7  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

BM8 Learn of the ASX-listed company that is well-placed to respond to the future global energy demand
right-arrow Created with Sketch.
NVU Nanoveu commences crucial benchmark testing for System-on-aChip (SoC) Semiconductor technology
right-arrow Created with Sketch.
NEWS ClearVue successfully raises $7.5 million via institutional placement
right-arrow Created with Sketch.
LGP Record revenue of $10.2 million as European demand drives 40% quarterly growth, with $1 million in operating cash inflow and $0.5 million in cost savings forecast
right-arrow Created with Sketch.
NEWS Trending Thread: $13.0 million Institutional Placement
right-arrow Created with Sketch.
NEWS First-ever treatment for Rett syndrome approved in Canada, opening new possibilities for patients and boosting potential royalty payments—discover more about DAYBUE™'s breakthrough
right-arrow Created with Sketch.
watchlist Created with Sketch. Add NEA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.